TECOS VISITA 202324

TECOS VISITA 202324 tecos TECOS executive committee, “There was no hint of heart failure seen in the sitagliptin-treated patients relative to placebo Given the size tecos Follow Tecos v Apodaca results, h2h statistics, latest results, news and more information on Flashscore

tecos TECOS is a randomized, double-blind, controlled trial comparing sitagliptin and placebo when added to best usual care in patients with T2DM and cardiovascular

tecos Some rare safety concerns still remain , see uncertainties, page 2 • Neutral CV results with TECOS and Some rare safety concerns still remain , see uncertainties, page 2 • Neutral CV results with TECOS and